According to new data from SullivanCotter, compensation in the United States is up more than 20% in the last five years for interventional cardiology, electrophysiology, general cardiology and vascular surgery. This points to a workforce that is getting more competitive over time, one expert told Cardiovascular Business.

“Patients are in desperate need of an effective treatment, and we are doing everything we can to help find that treatment,” one scientist explained. “The greatest reward would be to see a safe and effective treatment for people who currently have very few options.”

Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can be expanded using a transcatheter procedure.

The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It covers robotic systems of all types, including those used for various cardiac procedures. 

At Mass General Brigham, advanced algorithms help clinicians spend more time focused on what matters most.

Cardiologists have always wanted a better way to identify heart patients in need of care early in their course of disease. Artificial intelligence may be the tool physicians have been waiting for. 

Clinicians can continue using these devices as they await a replacement. The FDA first issued an early alert about this issue in August. 

A new analysis found that one approach may outperform the other when it comes to minimizing the patient's risk of major cardiovascular events.

A new survey put a spotlight on the staffing issues rural cardiology practices and health systems face on a daily basis. 

The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS.